Opinion
Video
The panelists highlight key takeaways for payors involved in MDS treatment.
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Challenges and Opportunities for AI in Melanoma Detection
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
FDA Expands Access to Approved CAR T-Cell Therapies by Eliminating REMS
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
Marstacimab Improved Key Bleeding Outcomes in Hemophilia A or B
First-Line Rucaparib Maintenance Reduces Progression Risk Across Prognostic Subgroups in HRD– High-Grade Ovarian Cancer